Fish Oil GP - References

I Product Info I Ingredients I Recommended Use I Clinical Trials I Research Brief I References

fishoillg

 

Order this item

Indication: cardiovascular disease prophylaxis, high cholesterol level, impaired blood vessel elasticity, impaired liver and gallbladder functions, dry skin, for overall health improvement.

Actions: delivers polyunsaturated fatty acids, essential for good health, supports the cardiovascular system, lowers triglyceride levels, helps maintain healthy cholesterol levels, prevents plaque formation on the blood vessel walls, improves elasticity, improves blood circulation, lowers lithogenicity of bile, essential for the normal brain function, improves the body’s immune respons.

Ingredients (per 1 softgel):

Vitamin E (as dl-alpha-tocopheryl acetate) - 1 IU, Fish  Oil - 1000.0 mg, Eicosapentaenoic Acid - 180.0 mg, Docosahexaenoic Acid - 120.0 mg.

Low USA domestic & international shipping

 

Fish Oil GP - References:

  1. Simopoulos, Artemis. Omega-3 fatty acids in health and disease and in growth and development. American Journal of Clinical Nutrition, Vol. 54, 1991, pp. 438-63

  2. Pepping, Joseph. Omega-3 essential fatty acids. American Journal of Health-System Pharmacy, Vol. 56, April 15, 1999, pp. 719-24

  3. Uauy-Dagach, Ricardo and Valenzuela, Alfonso. Marine oils: the health benefits of n-3 fatty acids. Nutrition Reviews, Vol. 54, November 1996, pp. S102-S108

  4. Connor, William E. Importance of n-3 fatty acids in health and disease. American Journal of Clinical Nutrition, Vol. 71 (suppl), January 2000, pp. 171S-75S

  5. US Food and Drug Administration (September 8, 2004). FDA Announces Qualified Health Claims for Omega-3 Fatty Acids.

  6. "The effect of docosahexaenoic acid on aggression in young adults: a placebo-controlled double-blind study," T. Hamazaki, S. Sawazaki, M. Itomura, E. Asoka, Y. Nagao, N. Nishimura, K. Yazawa, T. Kuwamori, and M. Kobayashi, Journal of Clinical Investiga ation, Vol. 97, 1996, pp. 1129-1133.

  7. Kremer, Joel M., et al. Fish-oil fatty acid supplementation in active rheumatoid arthritis: A double-blinded, controlled, crossover study. Annals of Internal Medicine, Vol. 106, April 1987, pp. 497-503

  8. Kremer, Joel M. n-3 fatty acid supplements in rheumatoid arthritis. American Journal of Clinical Nutrition, Vol. 71 (suppl), January 2000, pp. 349S-51S

  9. J. Stevens, S. S. Zentall, M. L. Abate, T. Kuczek, and J. R. Burgess. "Omega-3 fatty acids in boys with behavior, learning, and health problems,"conference abstract,1995.

  10. Simopoulos AP, Leaf A, Salem Jr N. Statement on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Prostaglandins, Leukotrienes and Essential Fatty Acids 2000;63:119-121.

  11. J Am Coll Cardiol 2006;98:1393-5.

  12. British Journal of Cancer (doi: 10.1038/sj.bjc.6603030),

  13. D. Morgan, L. Dixon, C. Hanratty, N. El-Sherbeeny, P. Hamilton, L. McGrath, W. Leahey, G. Johnston, G. McVeigh. Effects of Dietary Omega-3 Fatty Acid Supplementation on Endothelium-Dependent Vasodilation in Patients With Chronic Heart Failure.  Am J Cardiol 2006;97:547-51.

  14. T. L. Huang, PhD, P. P. Zandi, PhD, K. L. Tucker, PhD, A. L. Fitzpatrick, PhD, L. H. Kuller, MD, Dr PH, L. P. Fried, MD, MPH, G. L. Burke, MD, MS and M. C. Carlson, PhD Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. NEUROLOGY 2005;65:1409-1414

  15. Fortin, Paul R., et al. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. Journal of Clinical Epidemiology, Vol. 48, 1995, pp. 1379-90

  16. Geusens, Piet, et al. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arthritis & Rheumatism, Vol. 37, June 1994, pp. 824-29

  17. Bittiner, S.B., et al. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. The Lancet, February 20, 1988, pp. 378-80

  18. Wang C, Harris WS, Chung M, et al. n-3 fatty acids from fish or fish-oil supplmenets but not a-linoleic acid, benefit cardiovascular outcomes in primary and secondary prevention studies: a systematic review. Am J. Clin Nutr 2006;84:5-17

  19. Mozaffarian D, & Rimm EB. Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits. JAMA, October 18, 2006—Vol 296, No.15

  20. T. Hamazaki, S. Sawazaki, M. Itomura, E. Asoka, Y. Nagao, N. Nishimura, K. Yazawa, T. Kuwamori, and M. Kobayashi "The effect of docosahexaenoic acid on aggression in young adults: a placebo-controlled double-blind study,", Journal of Clinical Investigation, Vol. 97, 1996, pp. 1129-1133.

  21. J Am Coll Cardiol 2006;48:1600-6.

  22. M. Elizabeth Sublette, M.D., Ph.D., Joseph R. Hibbeln, M.D., Hanga Galfalvy, Ph.D., Maria A. Oquendo, M.D. and J. John Mann, Ph.D. Omega-3 Polyunsaturated Essential Fatty Acid Status as a Predictor of Future Suicide Risk. Am J Psychiatry 2006; 163: 52